Press Releases

Funds To Be Used To Continue Development of Two Drug Candidates Into Phase 2 Human Clinical Trials

RADNOR, Pa.--(BUSINESS WIRE)-- PolyMedix Inc. (OTC BB: PYMX, http://polymedix.com), an emerging biotechnology company developing acute care therapeutic drug products for infectious diseases and cardiovascular disorders, announced today the pricing of a registered public offering of up to 21,000,000 units consisting of shares and warrants for $1.00 per unit, or a total of up to $21 million in gross proceeds. The units consist of one share of PolyMedix common stock and a five year warrant to purchase 0.30 shares of PolyMedix common stock at $1.25 per share. The units will not be certificated and the shares and warrants will be immediately separable and transferable upon issuance. Merriman Curhan Ford (Nasdaq: MERR) acted as lead placement agent in this offering with Boenning & Scattergood, Inc. and Noble Financial Capital Markets serving as co-placement agents. Fordham Financial Management, Inc. acted as a selected dealer in the offering.

The net proceeds of the offering, which is expected to close on November 16, 2009 subject to certain customary closing conditions, will be used primarily to continue the clinical development of two drug candidates, PMX-30063 antibiotic and PMX-60056 heparin antagonist, into Phase 2 human clinical trials in 2010.

A registration statement relating to the offering was declared effective by the Securities and Exchange Commission on November 10, 2009, and the public offering is being made by means of a prospectus. A copy of the prospectus for the unit offering may be obtained by contacting Merriman Curhan Ford & Co., 135 East 57th Street, 24th Floor, New York, New York 10022, Attention: Warren Dunnavant. The prospectus will also be available on the Securities and Exchange Commission website at http://www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the laws of any such state.

About PolyMedix, Inc.

PolyMedix is a publicly traded emerging biotechnology company focused on addressing large market opportunities relating to the development of novel drugs and biomaterials for the treatment of infectious diseases and acute cardiovascular disorders. Specifically, PolyMedix is dedicated to research in product areas involving fast and inexpensive trials, straightforward endpoints and early clinical proof of concept. PolyMedix's compounds are based on biomimetics: non-peptide small molecule drug candidates that mimic the activity of proteins. The Company's antibiotic compounds, including PMX-30063 - small molecule mimetics of human host-defense proteins - have a mechanism of action distinct from those of current antibiotic drugs, a mechanism that is intended to make bacterial resistance unlikely to develop. The Company's goal is to develop these as rapidly acting antibiotics for serious systemic and local infections. The Company plans to continue the development of polymeric formulations as antimicrobial biomaterials, which can be used as additives to paints, plastics, and textiles to create self-sterilizing products and surfaces. The Company's heptagonist compounds, including PMX-60056, reverse the activity of both heparin and Low Molecular Weight Heparins, with the goal of developing an antagonist drug for LMWHs, and that is safer and easier to use than currently approved therapy for heparin. For more information, please visit PolyMedix at www.polymedix.com.

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that could cause PolyMedix's actual results and experience to differ materially from anticipated results and expectations expressed in these forward looking statements. PolyMedix has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal", "potential," "may," "suggest," and similar expressions. Among other factors that could cause actual results to differ materially from those expressed in forward-looking statements, PolyMedix's compounds may not enter or successfully complete clinical testing, or be granted regulatory approval to be sold and marketed in the United States or elsewhere. A more complete description of these factors is included in PolyMedix's filings with the Securities and Exchange Commission. You should not place undue reliance on any forward-looking statements. PolyMedix undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.

    Source: PolyMedix Inc.

LEWISBERRY, PA -- (MARKET WIRE) -- 11/11/09 -- As announced on 1 September 2009, Unilife Medical Solutions Limited ("Unilife" or "the Company") (ASX: UNI) (PINKSHEETS: UNIFF) is currently undertaking a transaction to redomicile the Unilife group in the United States of America ("US") and is also seeking to list on NASDAQ.

With a view to strengthening the credentials of the Unilife board prior to Unilife's redomiciliation in the US ("Proposed Transaction") and to meet NASDAQ independence requirements, the Company today announced it has appointed Mr John M. Lund to its Board of Directors as a non-executive member.

Mr Lund, a Certified Public Accountant, joins the Unilife Board of Directors as its fifth member. As Unilife prepares to list on NASDAQ, the addition of Mr Lund is particularly important as he brings to the Board valuable expertise in the areas of SEC reporting and compliance, mergers and acquisitions, and financial analysis that qualify him to serve as Chairman of the Audit Committee following Unilife's proposed listing on NASDAQ.

Mr Lund has held a number of distinguished, senior appointments in the fields of finance and accounting. In the past year, he served as an acquisition accounting consultant to support a major merger project being undertaken by a NYSE-listed multinational S&P 500 security technology company. In 2008, he was Vice President and Controller of Nexstar Broadcasting Group, Inc, a NASDAQ listed television broadcasting company. Prior to Nexstar he served as the Vice President of Finance and Corporate Controller for LQ Management, which operates more than 575 hotels across North America. Between 1997 and 2001, he held the position of Chief Financial Officer at North American telecommunications company CS Wireless Systems, an SEC registrant that was acquired by MCI (also a NASDAQ company) in 1999. While at KPMG (Peat Marwick) between 1991 and 1996, Mr Lund also assisted publicly listed companies with SEC compliance and financial audits.

Mr Lund holds a Bachelor of Science in Accounting from the University of North Texas (US) and is a member of the Financial Executives Institute.

Comments by Unilife Non-Executive Chairman Mr Jim Bosnjak OAM

"We are pleased to welcome an individual of John's calibre to the Board of Unilife. The appointment of John will bolster the strength and breadth of our Board as we progress towards a NASDAQ listing. I believe that John's background and experience will make him an ideal Chairman of our Audit Committee following the completion of our proposed listing on NASDAQ."

Comments by Mr John Lund

"I am honoured to be associated with Unilife, and look forward to supporting the continued expansion of the Company in the US as it seeks to become a global industry leader. Unilife has generated significant momentum during the past two years as it has moved to transition itself to being a US-based company. I believe Unilife is well-suited to being listed on the NASDAQ exchange, given its expanding relationships with pharmaceutical companies and strong cash-position."

The Company is also pleased to announce that as part of the Proposed Transaction, all of the existing directors of Unilife Medical Solutions Limited, including Mr Lund, have now been appointed to the Board of Unilife Corporation, which will be the parent company of the Unilife group following the Proposed Transaction.

Issue of Incentives to Directors

In recognition of the efforts and contributions that the directors of Unilife have made to the business and its operational activities, as well as to reflect the greater level of fiduciary responsibility following the completion of the Proposed Transaction, the Company has agreed to grant the following incentives to its directors:

--  600,000 options to each of Mr Jeff Carter, Mr John Lund and Mr William
    Galle under the Employee Share Option Plan of Unilife Medical Solutions
    Limited with an exercise price of A$1.20 subject to approval by
    shareholders as referred to below. These options would be exchanged for
    options in Unilife Corporation on a  6 to 1 basis (ie 100,000 Unilife
    Corporation options) upon completion of the Proposed Transaction;

--  10,000 shares of restricted stock in Unilife Corporation to be granted
    to each director (other than Mr Alan Shortall) under the Unilife
    Corporation 2009 Stock Incentive Plan provided that the share scheme of
    arrangement which will effect the proposed redomiciliation ("Share Scheme")
    is approved by shareholders and the Federal Court.
    

Shares of restricted stock are a form of US security which are not available in Australian companies but which are commonly used in the United States as a form of incentive for executives and / or directors. There is no exercise price payable on shares of restricted stock granted under the Unilife Corporation 2009 Stock Incentive Plan. Instead, shares of restricted stock are issued at the grant date and are subject to forfeiture in certain events and to transfer restrictions that fall away upon specified vesting dates over a three year period or upon certain conditions being met.

If the Share Scheme is not approved by shareholders and the Federal Court and consequently the Proposed Transaction does not proceed, each director (other than Alan Shortall) will receive 60,000 fully paid ordinary shares in the Company, to be issued over a three year period, instead of the 10,000 shares of restricted stock in Unilife Corporation.

The grant of the incentives to each of the directors identified above is subject to shareholder approval being obtained for their issue at an Extraordinary General Meeting ("EGM") of the Company which is scheduled to occur on or around 8 January 2010. Full details of the principal terms on which the options and shares of restricted stock or shares in the Company will be issued will be set out in the Notice of EGM which will be sent to shareholders in early December 2009.

In connection with the Proposed Transaction, the Unilife group is also considering providing a new equity incentive package to its Chief Executive Officer, Mr Alan Shortall, as he has now met all of the share price milestones included under his previous equity incentive package. Details of the new equity incentive package, which is to be structured in conjunction with the recommendations of an independent remuneration consultant and the Unilife Corporation remuneration committee to incentivise Mr Shortall to further develop the Company's business going forward, will be disclosed to the market once finalised and will also be subject to shareholder approval at the Unilife EGM in January 2010.

About Unilife

Unilife Medical Solutions Ltd is an ISO 13485 certified company that designs, develops and supplies innovative safety medical devices. Listed on the Australian Securities Exchange (ASX: UNI) since 2002, Unilife has FDA-registered manufacturing facilities in the US State of Pennsylvania and a proprietary portfolio of clinical and prefilled safety syringes designed for use within healthcare and pharmaceutical markets.

Shareholder / Analyst Enquiries:

Australia
Jeff Carter
Phone: + 61 2 8346 6500

United States
Stuart Fine
Phone: + 1 908 469 1788

HARBIN, China, Nov. 11, 2009 /PRNewswire-Asia-FirstCall/ -- China Education Alliance, Inc. (NYSE Amex: CEU), a China-based education resource and services company, will hold a conference call on Tuesday, November 17 to discuss financial results for the third quarter ended September 30, 2009. The conference call is scheduled for 10:00 a.m. Eastern standard time (7:00 a.m. Pacific).

To participate in the call, please dial (877) 407-0789, or (201) 689-8562 for international calls, approximately 10 minutes prior to the scheduled start time. Interested parties may also listen via a live Internet webcast, which can be found at the Company's website at http://www.chinaeducationalliance.com .

A replay of the call will be available for two weeks from 1:00 p.m. EST on November 17, 2009, until 11:59 p.m. EST on December 1, 2009. The number for the replay is (877) 660-6853, or (201) 612-7415 for international calls. The passcode for the replay is 337623, and the account number is 3055. You will need both the passcode and the account number to listen to the replay. In addition, a recording of the call will be available via the company's website at http://www.chinaeducationalliance.com for one year.

A bout China Education Alliance, Inc.

China Education Alliance, Inc. (NYSE Amex: CEU) is a fast-growing, leading China-based company offering high-quality education resources and services to students ages 6 to 18 and adults ages 18+ (University students and professionals). For students ages 6 to 18, China Education Alliance, Inc. offers supplemental, online exam-oriented training materials and on-site exam-oriented training and tutoring services. The company is providing on-line, downloadable, famous teachers resources and on-site face-to-face instructions. All resources and tutoring services are provided by famous teachers within mainland China. The purpose of online exam-orientated resources and on-site tutoring is to help Chinese students ages 6 to 18 to pass the two most important and highly competitive exams in their educational career: senior high school entrance exam and college entrance exam. For graduates and professionals age 18+, China Education Alliance provides vocational training including IT and several professional training programs. In addition, the Company is providing comprehensive English programs that are taught by North American instructors to assist graduates and professionals in learning the English language, both written and conversational in order to better able them to work for a foreign corporation or work-study abroad. For more information about China Education Alliance, please visit http://www.chinaeducationalliance.com.

    For more information, please contact:

    Investor Relations:

     RedChip Companies, Inc.
     Dave Gentry, Investor Relations
     Tel:   +1-800-733-2447 x104
     Email: info@redchip.com
     Web:   http://www.RedChip.com

SOURCE China Education Alliance, Inc.

HENDERSON, NV -- (MARKET WIRE) -- 11/11/09 -- American Lithium Minerals Inc. (OTCBB: AMLM) www.americanlithium.com (the "Company") -- My name is Hugh Aird, and I am the new CEO of American Lithium Minerals Inc. (OTCBB: AMLM). It is my pleasure to issue this corporate status report to all our shareholders and any interested parties. In a very short period of time, American Lithium Minerals has garnered an exceptional amount of attention from the investment community due to our positioning in the emerging lithium sector. We have begun execution of a business plan that we believe should lead us to a dominant position in the discovery and production of Lithium. Lithium demand driven mainly by the escalation in production of hybrid-electric and electric cars, is expected to increase four-fold by 2017. Additionally, the price for this very rare commodity has risen dramatically in the last year as the world wide supply/demand status approaches severe levels. This is the opportunity American Lithium Minerals is now positioned to capitalize on; the following is a brief rundown of recent events that have put us in such an opportune situation.

--  6/16/09 - announced closing to acquire interest of 16,000 acres in the
    lithium-rich Montezuma Valley, Nevada.
--  9/23/09 - announced starting work on Montezuma Valley project,
    consisting of Gravity Survey and Electromagnetic Survey.
--  9/29/09 - appointed Former Vice-Chairman of Merrill Lynch Canada, Mr.
    Hugh Aird to head up Business Development and Mergers and Acquisitions for
    the company.
--  10/08/09 - appointed top Lithium Industry Executive, Ms. Judy Baker
--  11/03/09 - appointed former KPMG executive Mr. Chris Hobbs, CA to
    position of CFO
--  11/05/09 - announced Letter of Intent to Acquire Premier Lithium
    Property in Utah
--  In addition the company has also recently been added to the Byron
    Securities Lithium Index and the Agoracom 100 list.
    

We have made a great deal of progress in a short period of time, and have put the people into place with the expertise that can assist American Lithium Minerals garner and maintain a leadership role in the lithium sector.

We will continue to develop the properties under our control, while adding more geologic expertise, and will continue to search for properties and acquisitions that provide unique opportunities. I thank you for your interest in and support of American Lithium Minerals Inc., please visit our website at www.americanlithium.com and/or call our investor relations department at 877-717-2656.

Sincerely,

Hugh Aird

CEO-American Lithium Minerals, Inc.

About American Lithium Minerals

American Lithium Minerals Inc. is an early stage lithium exploration company engaged in evaluating, developing and acquiring lithium projects, with a focus on the USA.

Forward-Looking Statements

This current report contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, future prices for lithium carbonate (Li2CO3), that lithium-ion battery demand for hybrid-electric and electric cars is expected to increase four fold by 2012, that demand for lithium-powered vehicles is expected to increase fivefold by 2012, or the existence of any commercially recoverable lithium carbonate on the Green Energy lithium project in Utah.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration and difficulties associated with obtaining financing on acceptable terms. We are not in control of lithium prices and these could vary to make development uneconomic. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

For Additional Information, Contact:
Stephen Cook
Vice President/Investor Relations
Tel: 877-717-2656
E-mail: info@americanlithium.com
Web: www.americanlithium.com

MELVILLE, N.Y.--(BUSINESS WIRE)-- Verint(R) Systems Inc. today announced upcoming customer and market events showcasing the ways global organizations are capitalizing on workforce optimization (WFO) technology, such as quality monitoring/recording, workforce management (WFM) and analytics, to improve efficiencies, streamline operations and enhance the customer experience.

Verint Online Event

"Smart Strategies for Retaining High-Value Customers"Webinar

November 12

Joining Oscar Alban of Verint Witness Actionable Solutions for this November 12,
2 p.m. ET webinar will be Brynn Palmer, an industry authority known as The
Customer Experience Doctor. Together, these seasoned practitioners will explore
the importance of and "how to's" around building customer loyalty both in up and
down economic times. Key topics will cover ways to gain insight and take action
on the feedback customers provide, how surveying can help build a strong
alliance between customer service and marketing teams, and how to instill a
customer-centric approach to operations. Protecting and retaining customers,
supporting sales and preserving brand equity are key, and now's the time to
invest in these vital areas. In this session, attendees will find out why and
how.

NSC Group and Verint Breakfast Briefing

"Enterprise Workforce Optimization"

November 12

Burswood Entertainment Complex, Burswood, Australia

During this breakfast roundtable on November 12 from 7:45 - 9:30 a.m. WST, Andy
Hawkes from Verint Witness Actionable Solutions will serve as a guest speaker
and explore the considerations and first steps toward an enterprise-wide
workforce optimization (WFO) strategy. During the session, attendees will gain
insights into implementing a WFO strategy with supporting processes and
solutions, how these are helping organizations around the world reduce
operations costs while improving the customer experience, and why the contact
center is considered a "cornerstone" for applications such as workforce
management (WFM) and recording, as well as such rapidly evolving and dynamic
solutions as speech analytics and customer feedback surveys.

CustomerThink Showcase Online Event

"Speech Analytics: Mining Customer Voices for Business Insight"

November 12

On November 12 at 10 a.m. PT, Diego Lomanto of Verint Witness Actionable
Solutions will participate in an online speech analytics discussion and product
demonstration of Verint's Impact 360(R) Speech Analytics software. Most contact
centers record customer conversations, yet many fail to utilize them as a
strategic resource. Dialogue between customers and agents can provide valuable
insight into rising issues, competitive intelligence, emerging trends and the
root causes prompting customer calls into the contact center. During this
session, Diego will highlight the role speech analytics technology can have in
the call center and the widespread impact it can have in making it an
intelligence hub and central point to customer service operations
enterprise-wide.

Workforce Optimization Creative Practices Workshop

Verint Regional Event

December 1

Renaissance Boston Waterfront Hotel, Boston, Mass.

Kathleen Peterson, founder and chief vision officer for Powerhouse Consulting,
will be a featured speaker at Verint's half-day creative practices workshop in
Boston on December 1. Taking place from 8:30 a.m. - 1 p.m. ET, the event will
explore valuable tips and takeaways for optimizing the customer experience to
satisfy both the needs of customers and the business -- along with contact
center and broader enterprise creative practices that can be put into action
today. A series of interactive discussions will round out the agenda.

For more information about Verint Systems or these upcoming events, please visit www.verint.com.

About Verint Witness Actionable Solutions

Verint(R) Witness Actionable Solutions(R) is the leader in analytics-driven workforce optimization software and services. Its solutions are designed to help organizations capture customer intelligence, uncover business trends, discover the root cause of employee and customer behavior, and optimize the customer experience. From contact centers to remote office, branch and back-office operations, its award-winning, next-generation Impact 360(R) Workforce Optimization suite is the industry's most unified solution set--featuring quality monitoring and recording, workforce management, speech and data analytics, customer feedback surveys, performance management, eLearning and coaching. Impact 360 helps improve the entire customer service delivery network, powering the right decisions to help ensure service excellence and transform organizations into customer-centric enterprises.

About Verint Systems Inc.

Verint(R) Systems Inc. (VRNT.PK), headquartered in Melville, New York, is a leading provider of Actionable Intelligence(R) solutions for an optimized enterprise and a safer world. Today, more than 10,000 organizations in over 150 countries rely on Verint solutions to perform more effectively, build competitive advantage and enhance the security of people, facilities and infrastructure. Visit us at our website www.verint.com.

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding expectations, predictions, views, opportunities, plans, strategies, beliefs, and statements of similar effect relating to Verint Systems Inc. These forward-looking statements are not guarantees of future performance and they are based on management's expectations that involve a number of risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. For a detailed discussion of these risk factors, see the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 10, 2007, as supplemented by our Current Reports on Form 8-K filed on November 5, 2007, January 16, 2008, and April 9, 2008 and the Form NT-10Q filed on September 9, 2009. The forward-looking statements contained in this press release are made as of the date of this press release and, except as required by law, the Company assumes no obligation to update or revise them or to provide reasons why actual results may differ.

VERINT, the VERINT logo, ACTIONABLE INTELLIGENCE, POWERING ACTIONABLE INTELLIGENCE, WITNESS ACTIONABLE SOLUTIONS, STAR-GATE, RELIANT, VANTAGE, X-TRACT, NEXTIVA, EDGEVR, ULTRA, AUDIOLOG, WITNESS, the WITNESS logo, IMPACT 360, the IMPACT 360 logo, IMPROVE EVERYTHING, EQUALITY, CONTACTSTORE, EYRETEL, BLUE PUMPKIN SOFTWARE, BLUE PUMPKIN, the BLUE PUMPKIN logo, EXAMETRIC and the EXAMETRIC logo, CLICK2STAFF, STAFFSMART, AMAE SOFTWARE and the AMAE logo are trademarks and registered trademarks of Verint Systems Inc. Other trademarks mentioned are the property of their respective owners.

    Source: Verint Systems Inc.